For a decade, CAR-T therapies such as Bristol Myers Squibb’s Abecma and Breyanzi, Gilead Sciences’ Yescarta and Tecartus, ...

Since the conflict between the medical community and the government began in February 2024, more than 3,000 medical students ...

Soon Chung Hyang University Hospital Cheonan said Wednesday that Professor Lee Han-yu of the Department of Emergency Medicine ...

With the recent reimbursement launch of Ebglyss (ingredient: lebrikizumab), a new biologic treatment developed by Eli Lilly, ...

Seven healthcare workers were secondarily infected with severe fever with thrombocytopenia syndrome (SFTS) after being exposed to blood and body fluids while performing CPR on a tick-borne patient, th ...

Many people think that surgical scars are incurable, but this is not the case.Patients experience skin problems during cancer ...

A Seoul doctor who profited from administering psychotropic drugs to propofol addicts under the guise of cosmetic procedures ...

Sydney’s Nepean Diagnostics, a private imaging center within Nepean Private Hospital, has become the beachhead for Coreline ...

Korea-based medical AI company AITRICS has shown that gaps in electronic health-record data can carry valuable clinical ...

Kuhnil Pharm has named former Takeda Korea General Manager Moon Hee-seok as its new co-CEO.Moon will oversee the company’s ...

Samsung Bioepis is handing its newest denosumab copycat, Xbryk, a biosimilar to Amgen’s bone cancer drug Xgeva, to longtime ...

Korea is emerging as a global center of excellence in the field of digestive endoscopy.The country is playing a pivotal role ...